ATE454148T1 - Acylierte piperidinderivative als melanocortin-4- rezeptoragonisten - Google Patents

Acylierte piperidinderivative als melanocortin-4- rezeptoragonisten

Info

Publication number
ATE454148T1
ATE454148T1 AT05773009T AT05773009T ATE454148T1 AT E454148 T1 ATE454148 T1 AT E454148T1 AT 05773009 T AT05773009 T AT 05773009T AT 05773009 T AT05773009 T AT 05773009T AT E454148 T1 ATE454148 T1 AT E454148T1
Authority
AT
Austria
Prior art keywords
acylated
melanocortin
derivatives
piperided
receptor agonists
Prior art date
Application number
AT05773009T
Other languages
English (en)
Inventor
Raman Bakshi
James Dellureficio
Ravi Nargund
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE454148T1 publication Critical patent/ATE454148T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT05773009T 2004-07-19 2005-07-15 Acylierte piperidinderivative als melanocortin-4- rezeptoragonisten ATE454148T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58908904P 2004-07-19 2004-07-19
PCT/US2005/025505 WO2006020277A2 (en) 2004-07-19 2005-07-15 Acylated piperidine derivatives as melanocortin-4 receptor agonists

Publications (1)

Publication Number Publication Date
ATE454148T1 true ATE454148T1 (de) 2010-01-15

Family

ID=35907993

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05773009T ATE454148T1 (de) 2004-07-19 2005-07-15 Acylierte piperidinderivative als melanocortin-4- rezeptoragonisten

Country Status (9)

Country Link
US (1) US7618987B2 (de)
EP (1) EP1773338B1 (de)
JP (1) JP2008506779A (de)
CN (1) CN1988906A (de)
AT (1) ATE454148T1 (de)
AU (1) AU2005274701A1 (de)
CA (1) CA2574156A1 (de)
DE (1) DE602005018779D1 (de)
WO (1) WO2006020277A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090181975A1 (en) * 2008-01-15 2009-07-16 Forest Laboratories Holdings Limited Nebivolol in the treatment of sexual dysfunction
UA99555C2 (en) 2008-11-12 2012-08-27 Элджи Лайф Саенсез Лтд. Melanocortin receptor agonists
US9044606B2 (en) 2010-01-22 2015-06-02 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue using electrical energy
US8476227B2 (en) 2010-01-22 2013-07-02 Ethicon Endo-Surgery, Inc. Methods of activating a melanocortin-4 receptor pathway in obese subjects
CN104974017B (zh) * 2014-04-09 2017-11-17 上海医药工业研究院 (1r,2s)‑2‑(3,4‑二氟苯基)环丙胺·d‑扁桃酸盐的制备方法
US10080884B2 (en) 2014-12-29 2018-09-25 Ethicon Llc Methods and devices for activating brown adipose tissue using electrical energy
US10092738B2 (en) 2014-12-29 2018-10-09 Ethicon Llc Methods and devices for inhibiting nerves when activating brown adipose tissue
PT3333165T (pt) * 2015-08-04 2019-10-29 Astellas Pharma Inc Derivado de piperazina
CN109563074B (zh) 2016-07-19 2021-09-28 安斯泰来制药株式会社 哌嗪衍生物
EP3886854A4 (de) 2018-11-30 2022-07-06 Nuvation Bio Inc. Pyrrol- und pyrazolverbindungen und verfahren zu deren verwendung
US11590209B2 (en) 2020-01-21 2023-02-28 Palatin Technologies, Inc. Use of bremelanotide in patients with controlled hypertension

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294534B1 (en) * 1998-06-11 2001-09-25 Merck & Co., Inc. Spiropiperidine derivatives as melanocortin receptor agonists
WO1999064002A1 (en) 1998-06-11 1999-12-16 Merck & Co., Inc. Spiropiperidine derivatives as melanocortin receptor agonists
CA2377369A1 (en) * 1999-06-04 2000-12-14 Merck & Co., Inc. Substituted piperidines as melanocortin-4 receptor agonists
HRP20020737A2 (en) 2000-02-11 2005-10-31 Vertex Pharmaceuticals Incorporated Piperazine and piperidine derivatives for treatment or prevention of nruronal damage
EP1268449A4 (de) * 2000-03-23 2004-09-15 Merck & Co Inc Substituierte piperidine als melanokortin-rezeptor-agonisten
EP1268000A4 (de) 2000-03-23 2004-12-29 Merck & Co Inc Spiropiperidinderivate als melanocortin-rezeptor agonisten
AU2001264977B2 (en) 2000-05-30 2005-04-14 Merck & Co., Inc. Melanocortin receptor agonists
CA2419310A1 (en) 2000-08-23 2002-02-28 Merck & Co., Inc. Substituted piperidines as melanocortin receptor agonists
GEP20053710B (en) 2001-02-28 2005-12-26 Merck & Co Inc Acylated Piperidine Derivatives as Melanocortin-4 Receptor Agonists
EP1385506B1 (de) 2001-02-28 2009-05-06 Merck & Co., Inc. Acylierte piperidinderivate als melanocortin-4-rezeptoragonisten
EP1372653B1 (de) 2001-02-28 2006-10-04 Merck & Co., Inc. Acylierte piperidin-derivate als melanocortin-4-rezeptor-agonisten
WO2002079146A2 (en) * 2001-03-02 2002-10-10 Bristol-Myers Squibb Company Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
US7115628B2 (en) 2001-07-18 2006-10-03 Merck & Co., Inc. Bridged piperidine derivatives as melanocortin receptor agonists
US6977264B2 (en) 2001-07-25 2005-12-20 Amgen Inc. Substituted piperidines and methods of use
US7507753B2 (en) 2001-12-28 2009-03-24 Takeda Chemical Industries Ltd. Biaryl compound and use thereof
US20030195187A1 (en) 2002-02-04 2003-10-16 Chiron Corporation Guanidino compounds
AU2003216274A1 (en) 2002-02-11 2003-09-04 Neurocrine Biosciences, Inc. Pyrrole derivatives as ligands of melanocortin receptors
US20040010010A1 (en) 2002-04-30 2004-01-15 Ebetino Frank Hallock Melanocortin receptor ligands
WO2004024720A1 (en) 2002-09-11 2004-03-25 Merck & Co., Inc. Piperazine urea derivatives as melanocortin-4 receptor agonists
TW200504033A (en) 2002-10-23 2005-02-01 Procter & Gamble Melanocortin receptor ligands
AR043434A1 (es) 2003-03-03 2005-07-27 Merck & Co Inc Derivados de piperizacina acilados como agonistas del receptor de melanocortina-4. composiciones farmaceuticas y usos

Also Published As

Publication number Publication date
AU2005274701A1 (en) 2006-02-23
DE602005018779D1 (de) 2010-02-25
WO2006020277A2 (en) 2006-02-23
CN1988906A (zh) 2007-06-27
WO2006020277A3 (en) 2006-07-20
CA2574156A1 (en) 2006-02-23
EP1773338B1 (de) 2010-01-06
EP1773338A2 (de) 2007-04-18
US20070191433A1 (en) 2007-08-16
US7618987B2 (en) 2009-11-17
EP1773338A4 (de) 2007-08-01
JP2008506779A (ja) 2008-03-06

Similar Documents

Publication Publication Date Title
DE602004028228D1 (de) Bicyclische piperidin-derivate als melanocortin-4 rezeptor-agonisten
ATE358481T1 (de) Acylierte piperidinderivate als melanocortin-4- rezeptoragonisten
ATE430565T1 (de) Acylierte piperidinderivate als melanocortin-4- rezeptoragonisten
ATE341327T1 (de) Acylierte piperidin-derivate als melanocortin-4- rezeptor-agonisten
TW200508223A (en) Acylated piperazine derivatives as melanocortin-4 receptor agonists
ATE411021T1 (de) Überbrückte piperidinderivate als melanocortin- rezeptor-agonisten
MXPA05010724A (es) Derivados de las espiropiperidinas aciladas como agonistas del receptor de la melanocortina-4.
WO2005009950A3 (en) Piperidine derivatives as melanocortin-4 receptor agonists
NO20082011L (no) Acylerte spiropiperidinderivater som melanocortin-4-reseptormodulatorer
WO2008039418A3 (en) Acylated piperidine derivatives as melanocortin-4 receptor modulators
WO2007041061A3 (en) Acylated piperidine derivatives as melanocortin-4 receptor agonists
TW200510416A (en) P38 inhibitors and methods of use thereof
DE602005018779D1 (de) Acylierte piperidinderivative als melanocortin-4-rezeptoragonisten
WO2007047496A3 (en) Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
WO2006019787A3 (en) Acylated piperidine derivatives as melanocortin-4 receptor agonists
JO2351B1 (en) Derived bipridine derivatives as cofactors of melanocortin-4 receptor
DOP2004000838A (es) Derivados de piperizacina acilados como agonistas del receptor de melanocortina-4

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties